| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $64.61M | - | |
| VP | 66.5K | $32.19M | - | |
| VP | 51.1K | $24.72M | - | |
| VP | 42.3K | $20.47M | - | |
| Other | 24.0K | $11.63M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 4,058 | $485.49 | $1,970,118.42 | -6.9% | -8.4% | -1.7% | |
| Mar 3, 2025 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 3,231 | $490.00 | $1,583,190.00 | -9.8% | -7.8% | -1.9% | |
| Feb 27, 2025 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 530 | $475.34 | $251,930.20 | -0.9% | -6.2% | +4.7% | |
| Feb 27, 2025 | Atkinson Edward Morrow III49 | EVP, Chief Technical Ops. Off. | Sell | 2,650 | $475.34 | $1,259,651.00 | -12.0% | -6.2% | +4.7% | |
| Feb 27, 2025 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 1,272 | $480.00 | $610,560.00 | -3.7% | -6.2% | +4.7% | |
| Feb 25, 2025 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 354 | $480.95 | $170,256.30 | -0.5% | -7.2% | +0.6% | |
| Feb 25, 2025 | Ambrose Kristen | SVP &Chief Accounting Officer | Sell | 884 | $480.95 | $425,159.80 | -8.9% | -7.2% | +0.6% | |
| Feb 25, 2025 | Atkinson Edward Morrow III49 | EVP, Chief Technical Ops. Off. | Sell | 1,767 | $480.95 | $849,838.65 | -6.7% | -7.2% | +0.6% | |
| Feb 25, 2025 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 848 | $480.95 | $407,845.60 | -2.1% | -7.2% | +0.6% | |
| Feb 20, 2025 | Altshuler David48 | EVP, Chief Scientific Officer | Sell | 1,111 | $480.00 | $533,280.00 | -2.4% | -9.4% | -0.7% |